5-33989459-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014324.6(AMACR):c.783G>A(p.Met261Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,614,202 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_014324.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMACR | NM_014324.6 | c.783G>A | p.Met261Ile | missense_variant | 5/5 | ENST00000335606.11 | NP_055139.4 | |
C1QTNF3-AMACR | NR_037951.1 | n.1139G>A | non_coding_transcript_exon_variant | 9/9 | ||||
AMACR | NM_001167595.2 | c.783G>A | p.Met261Ile | missense_variant | 5/6 | NP_001161067.1 | ||
AMACR | NM_203382.3 | c.*25G>A | 3_prime_UTR_variant | 4/4 | NP_976316.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMACR | ENST00000335606.11 | c.783G>A | p.Met261Ile | missense_variant | 5/5 | 1 | NM_014324.6 | ENSP00000334424 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000283 AC: 43AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000955 AC: 24AN: 251278Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135824
GnomAD4 exome AF: 0.000101 AC: 147AN: 1461874Hom.: 0 Cov.: 34 AF XY: 0.000103 AC XY: 75AN XY: 727236
GnomAD4 genome AF: 0.000282 AC: 43AN: 152328Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74484
ClinVar
Submissions by phenotype
Alpha-methylacyl-CoA racemase deficiency Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 07, 2022 | This sequence change replaces methionine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 261 of the AMACR protein (p.Met261Ile). This variant is present in population databases (rs9282593, gnomAD 0.08%). This variant has not been reported in the literature in individuals affected with AMACR-related conditions. ClinVar contains an entry for this variant (Variation ID: 502794). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The isoleucine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
AMACR-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 21, 2024 | The AMACR c.783G>A variant is predicted to result in the amino acid substitution p.Met261Ile. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.076% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Congenital bile acid synthesis defect 4;C3280428:Alpha-methylacyl-CoA racemase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jun 29, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at